3.91
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché ACB Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.08
Aprire:
$4.11
Volume 24 ore:
2.33M
Relative Volume:
2.26
Capitalizzazione di mercato:
$326.56M
Reddito:
$195.82M
Utile/perdita netta:
$-88.78M
Rapporto P/E:
-1.5585
EPS:
-2.5089
Flusso di cassa netto:
$-88.86M
1 W Prestazione:
-36.42%
1M Prestazione:
-28.91%
6M Prestazione:
-8.86%
1 anno Prestazione:
-23.18%
Aurora Cannabis Inc. Stock (ACB) Company Profile
Nome
Aurora Cannabis Inc.
Settore
Telefono
-
Indirizzo
10355 Jasper Avenue, Suite 500, Edmonton, AB
Confronta ACB con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
ACB
Aurora Cannabis Inc.
|
3.91 | 326.56M | 195.82M | -88.78M | -88.86M | -2.5089 |
![]()
RGC
Regencell Bioscience Holdings Ltd
|
23.70 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
![]()
ZTS
Zoetis Inc
|
157.34 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
HLN
Haleon Plc Adr
|
10.49 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.72 | 47.39B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.97 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
Aurora Cannabis Inc. Stock (ACB) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-11 | Iniziato | TD Cowen | Buy |
2024-02-09 | Aggiornamento | Canaccord Genuity | Hold → Buy |
2022-09-21 | Aggiornamento | Canaccord Genuity | Sell → Hold |
2022-06-24 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
2022-06-06 | Aggiornamento | Stifel | Sell → Hold |
2021-09-28 | Aggiornamento | MKM Partners | Sell → Neutral |
2021-09-03 | Aggiornamento | Jefferies | Underperform → Hold |
2021-05-14 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
2021-05-14 | Downgrade | Canaccord Genuity | Hold → Sell |
2021-05-11 | Downgrade | CIBC | Neutral → Sector Underperform |
2021-04-28 | Ripresa | BofA Securities | Neutral |
2021-02-12 | Downgrade | Desjardins | Hold → Sell |
2021-02-12 | Downgrade | MKM Partners | Neutral → Sell |
2021-02-12 | Downgrade | Needham | Hold → Underperform |
2020-12-18 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
2020-11-16 | Downgrade | Jefferies | Hold → Underperform |
2020-11-11 | Downgrade | Stifel | Hold → Sell |
2020-10-27 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
2020-09-21 | Aggiornamento | Jefferies | Underperform → Hold |
2020-09-08 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
2020-06-24 | Aggiornamento | Stifel | Sell → Hold |
2020-05-22 | Downgrade | Jefferies | Hold → Underperform |
2020-05-15 | Aggiornamento | Piper Sandler | Underweight → Neutral |
2020-02-27 | Downgrade | Bryan Garnier | Neutral → Sell |
2020-02-25 | Iniziato | Needham | Hold |
2020-02-24 | Downgrade | Cowen | Outperform → Market Perform |
2020-02-14 | Aggiornamento | MKM Partners | Sell → Neutral |
2020-02-07 | Downgrade | Canaccord Genuity | Speculative Buy → Hold |
2020-01-10 | Downgrade | BofA/Merrill | Neutral → Underperform |
2020-01-10 | Downgrade | Piper Sandler | Overweight → Neutral |
2019-12-23 | Downgrade | Jefferies | Buy → Hold |
2019-11-15 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
2019-11-05 | Iniziato | Cantor Fitzgerald | Neutral |
2019-09-24 | Iniziato | CIBC | Neutral |
Mostra tutto
Aurora Cannabis Inc. Borsa (ACB) Ultime notizie
Aurora Cannabis Inc (ACB) (Q4 2025) Earnings Call Highlights: Re - GuruFocus
Aurora Cannabis Reports Record Revenue and Growth - TipRanks
Aurora Cannabis denies news of acquisition of New Zealand’s Medleaf Therapeutics - StratCann
Aurora Cannabis Refutes MedLeaf Acquisition Rumors - mg Magazine
Aurora Cannabis announces new strategic partnership - Investing.com
Aurora Cannabis (ACB) Denies Acquisition of MedLeaf Therapeutics - GuruFocus
Aurora Cannabis Denies Acquisition Rumors of MedLeaf Therapeutics - TipRanks
Aurora Cannabis denies acquisition of MedLeaf Therapeutics - Investing.com
Aurora Cannabis (ACB) Refutes Acquisition Rumors of MedLeaf Therapeutics | ACB Stock News - GuruFocus
Aurora Cannabis Denies News of Acquisition of MedLeaf Therapeutics | ACB Stock News - GuruFocus
Aurora Cannabis (ACB) Denies News of Acquisition of MedLeaf Therapeutics - StreetInsider
Aurora Cannabis Denies News Of Acquisition Of MedLeaf Therapeutics - Barchart.com
Cannabis Stock Movers For June 18, 2025 - Benzinga
EXCLUSIVE: Medical Cannabis Is Growing And Profitable, Says Aurora CEO — Investors Are Just Missing The Story - Benzinga
Aurora Cannabis Q4 2025 Earnings Call Transcript - MarketBeat
Aurora Cannabis: Poland Headwinds Result In Disappointing Outlook (Rating Downgrade) (ACB) - Seeking Alpha
Aurora Cannabis CEO touts ‘pristine’ balance sheet, but shares tumble - BNN Bloomberg
Aurora Cannabis pays $215 million to acquire MedLeaf Therapeutics - MJBizDaily
Aurora Cannabis announces strategic acquisition of MedLeaf Therapeutics By Investing.com - Investing.com India
Aurora Cannabis announces strategic acquisition of MedLeaf Therapeutics - Investing.com
Canadian Medical Marijuana Firm Aurora Cannabis Expects Weak Demand In International Market - Benzinga
Aurora Cannabis Stock Falls as Canadian Producer Expects International Sales to Decline - MSN
Aurora Cannabis (ACB) Reports Significant Q4 Revenue Growth - GuruFocus
Aurora Cannabis Inc. - Baystreet.ca
Aurora Cannabis (ACB) Shares Tumble After Earnings Report | ACB Stock News - GuruFocus
Aurora Cannabis (ACB) Shares Drop Despite Exceeding Revenue Expe - GuruFocus
Aurora Cannabis Inc. (ACB) Misses Q4 Earnings Estimates - Yahoo Finance
Aurora Cannabis, Bitdeer Technologies Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Aurora Cannabis drops despite Q4 beat amid concerns over international growth - MSN
Aurora Cannabis (NASDAQ:ACB) Posts Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat
Aurora Cannabis Achieves Record Revenue and EBITDA in Fiscal 2025 - TipRanks
Aurora Cannabis (ACB) Eyes First Profitable Year Amid Sector Cha - GuruFocus
Aurora Cannabis Files Full Year Results and Announces Fiscal 2025 Fourth Quarter - Placera.se
Aurora Cannabis Q4 Loss Narrows, Adj.EBITDA Surges; Sees Sequentially Weak Demand In Q1; Stock Drops - Nasdaq
ACB Projects Slight Dip in Q1 Revenue with Positive Cash Flow Ou - GuruFocus
Aurora Cannabis Q4 FY25 slides: positive cash flow achieved amid global expansion - Investing.com
Aurora Cannabis Files Full Year Results and Announces Fiscal 202 - GuruFocus
Aurora Cannabis (ACB) Reports Strong Q4 Adjusted EBITDA Growth | ACB Stock News - GuruFocus
ACB in charts: Q4 revenue from medical cannabis, plant propagation climb, consumer segment down - Seeking Alpha
Aurora Cannabis Files Full Year Results And Announces Fiscal 2025 Fourth Quarter - Barchart.com
Germany Legal Cannabis Market Report 2025-2030: Competitive - GlobeNewswire
Aurora Cannabis (ACB) Prepares for Earnings Announcement - GuruFocus
GMS, Korn/Ferry, Aurora Cannabis to report earnings Wednesday By Investing.com - Investing.com Nigeria
GMS, Korn/Ferry, Aurora Cannabis to report earnings Wednesday - Investing.com
Cannabis Hyperemesis Syndrome Class Action Certified - mg Magazine
Aurora Cannabis Faces Class Action Over Lack of Warnings About Cannabinoid Hyperemesis Syndrome - Cannabis Health News
What To Expect From Aurora Cannabis Inc (TSX:ACB) Q4 2025 Earnings - Yahoo Finance
Aurora Cannabis: Poised For Its First Profitable Year (NASDAQ:ACB) - Seeking Alpha
Earnings week ahead: KR, ACN, ACB, and more (NASDAQ:ACB) - Seeking Alpha
Aurora Cannabis (ACB) Projected to Post Earnings on Wednesday - MarketBeat
Cannabis Stock CGC Rallies 39% in Three Months: Time to Buy or Sell? - The Globe and Mail
Aurora Cannabis Inc. Azioni (ACB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):